Article 2 Amendment of Table A of Schedule 1 to the principal Order
Table A of Schedule 1 is amended as follows—
against the entry for Ibuprofenf1, there is inserted—
in column 2, after the entry numbered “(2)”, the words “(3) 2.0 per cent”;
in column 3, after the entry numbered “(2)”, the words “(3) Internal: liquid preparations, for the treatment of rheumatic or muscular pain, headache, dental pain, feverishness, or symptoms of colds and influenza for use in children aged under 12 years”; and
in column 4, after the entry numbered “(2)”, the words “(3) 200 mg (MD) 800 mg (MDD)”; and
against the entry for Potassium Chloride f2—
in column 2, the entry “0.15 per cent” is numbered “(1)”; and
in column 3, for the entry “Treatment of acute diarrhoea” there is substituted the entry “(1) Internal: for the treatment of acute diarrhoea” and, after that entry, there is inserted the entry “(2) External”.
In Table A of Schedule 1, there is inserted in column 1, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entries set out in column 1 below, and, against those entries, there is inserted in columns 2, 3 and 4 the corresponding text in columns 2, 3 and 4 below:
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| Substance | Maximum strength or maximum amount released | Use, pharmaceutical form or route of administration | Maximum dose and maximum daily dose |
| Cetirizine Hydrochloride | 10 mg | Tablets; for the symptomatic relief of perennial rhinitis, seasonal allergic rhinitis and idiopathic chronic urticaria in adults and in children aged 12 years and over | 10 mg (MDD) |
| Ibuprofen Lysine | Equivalent to 200 mg ibuprofen | Tablets; for the treatment of rheumatic or muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness or symptoms of colds and influenza in adults and in children aged 12 years and over | Equivalent to 400 mg ibuprofen (MD) Equivalent to 1200 mg ibuprofen (MDD) |
| Loratadine | 10 mg | Tablets; for the symptomatic relief of perennial rhinitis, seasonal allergic rhinitis and idiopathic chronic urticaria in adults and in children aged 12 years and over | 10 mg (MDD) |